CN104522649A - 一种含紫苏籽油的dha藻油软胶囊及其制备方法 - Google Patents
一种含紫苏籽油的dha藻油软胶囊及其制备方法 Download PDFInfo
- Publication number
- CN104522649A CN104522649A CN201410791031.3A CN201410791031A CN104522649A CN 104522649 A CN104522649 A CN 104522649A CN 201410791031 A CN201410791031 A CN 201410791031A CN 104522649 A CN104522649 A CN 104522649A
- Authority
- CN
- China
- Prior art keywords
- oil
- perilla seed
- dha
- soft capsule
- seed oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003921 oil Substances 0.000 title claims abstract description 56
- 235000019198 oils Nutrition 0.000 title claims abstract description 56
- 239000001335 perilla frutescens leaf extract Substances 0.000 title claims abstract description 41
- 239000007901 soft capsule Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims description 4
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 title abstract 10
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 title abstract 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- 239000003292 glue Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 239000011229 interlayer Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 108010010803 Gelatin Proteins 0.000 claims description 10
- 239000008273 gelatin Substances 0.000 claims description 10
- 229920000159 gelatin Polymers 0.000 claims description 10
- 235000019322 gelatine Nutrition 0.000 claims description 10
- 235000011852 gelatine desserts Nutrition 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000008213 purified water Substances 0.000 claims description 6
- 235000004347 Perilla Nutrition 0.000 claims description 5
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 5
- 239000006260 foam Substances 0.000 claims description 4
- 239000004519 grease Substances 0.000 claims description 4
- 238000009413 insulation Methods 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 23
- 241000195493 Cryptophyta Species 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000000295 complement effect Effects 0.000 abstract description 3
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 230000007547 defect Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 50
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 18
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- 235000019197 fats Nutrition 0.000 description 11
- 235000021323 fish oil Nutrition 0.000 description 11
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 9
- 229960004488 linolenic acid Drugs 0.000 description 9
- 239000002994 raw material Substances 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 238000003825 pressing Methods 0.000 description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 208000001953 Hypotension Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 208000021822 hypotensive Diseases 0.000 description 4
- 230000001077 hypotensive effect Effects 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 3
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000002402 anti-lipaemic effect Effects 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 229920001268 Cholestyramine Polymers 0.000 description 1
- 241000199914 Dinophyceae Species 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000003026 anti-oxygenic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000516 bezafibrate Drugs 0.000 description 1
- IIBYAHWJQTYFKB-UHFFFAOYSA-N bezafibrate Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1CCNC(=O)C1=CC=C(Cl)C=C1 IIBYAHWJQTYFKB-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 229960001214 clofibrate Drugs 0.000 description 1
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 1
- 239000012809 cooling fluid Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000007731 hot pressing Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960005436 inositol nicotinate Drugs 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- MFZCIDXOLLEMOO-GYSGTQPESA-N myo-inositol hexanicotinate Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](OC(=O)C=2C=NC=CC=2)[C@@H](OC(=O)C=2C=NC=CC=2)[C@@H]1OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-GYSGTQPESA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- -1 neutral fat) Chemical compound 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000003071 polychlorinated biphenyls Chemical class 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410791031.3A CN104522649B (zh) | 2014-12-18 | 2014-12-18 | 一种含紫苏籽油的dha藻油软胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410791031.3A CN104522649B (zh) | 2014-12-18 | 2014-12-18 | 一种含紫苏籽油的dha藻油软胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104522649A true CN104522649A (zh) | 2015-04-22 |
CN104522649B CN104522649B (zh) | 2016-08-17 |
Family
ID=52838426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410791031.3A Active CN104522649B (zh) | 2014-12-18 | 2014-12-18 | 一种含紫苏籽油的dha藻油软胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104522649B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104799298A (zh) * | 2015-05-20 | 2015-07-29 | 曾晓飞 | 一种以虾青素与欧米伽3结合的营养补充液 |
CN104856055A (zh) * | 2015-05-20 | 2015-08-26 | 曾晓飞 | 一种以虾青素与欧米伽3结合的食品补充剂 |
CN105124586A (zh) * | 2015-09-18 | 2015-12-09 | 青岛琅琊台集团股份有限公司 | 一种含葡萄籽油的dha藻油软胶囊复配及其制备方法 |
CN105768098A (zh) * | 2016-02-25 | 2016-07-20 | 深圳市荣格保健品有限公司 | 一种具有改善记忆力的藻油dha软胶囊及其制备方法 |
CN107997120A (zh) * | 2017-10-24 | 2018-05-08 | 深圳市麦金利实业有限公司 | 一种具有辅助改善记忆功能的软胶囊及其制备方法 |
CN108485793A (zh) * | 2018-03-30 | 2018-09-04 | 广州富诺营养科技有限公司 | 一种高稳定性dha藻油的制备方法 |
CN111685326A (zh) * | 2019-03-15 | 2020-09-22 | 王征 | 优你钙dha藻油制备方法 |
CN112273651A (zh) * | 2020-11-07 | 2021-01-29 | 润科生物工程(福建)有限公司 | 一种富含微藻油dha、dpa和epa的软胶囊及其制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1370544A (zh) * | 2001-02-27 | 2002-09-25 | 张洪超 | 一种具有降血脂作用的林蛙卵油营养保健胶囊及其制法 |
CN1370560A (zh) * | 2001-02-27 | 2002-09-25 | 廖秀义 | 益智、降血脂营养保健软胶囊及其制法 |
CN101002825A (zh) * | 2007-01-11 | 2007-07-25 | 西北农林科技大学 | 富含α-亚麻酸、杜仲有效成分的杜仲软胶囊的制备方法 |
CN102885310A (zh) * | 2012-10-19 | 2013-01-23 | 中科乐仁(北京)科技发展有限公司 | 一种辅助改善记忆的保健食品组合物及其制备方法 |
CN103238846A (zh) * | 2013-05-31 | 2013-08-14 | 烟台燕园科玛生物技术开发有限公司 | 一种α-亚麻酸软胶囊 |
CN103385315A (zh) * | 2013-08-06 | 2013-11-13 | 南京弘典医药科技有限公司 | 一种具有降血脂作用的植物油组合物及其制备方法与应用 |
CN103598587A (zh) * | 2013-11-20 | 2014-02-26 | 山西振东制药股份有限公司 | 一种具有辅助降血脂作用的保健食品及其制备方法 |
CN104256610A (zh) * | 2014-10-11 | 2015-01-07 | 汤臣倍健股份有限公司 | 一种辅助降血脂的保健组合物及软胶囊 |
-
2014
- 2014-12-18 CN CN201410791031.3A patent/CN104522649B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1370544A (zh) * | 2001-02-27 | 2002-09-25 | 张洪超 | 一种具有降血脂作用的林蛙卵油营养保健胶囊及其制法 |
CN1370560A (zh) * | 2001-02-27 | 2002-09-25 | 廖秀义 | 益智、降血脂营养保健软胶囊及其制法 |
CN101002825A (zh) * | 2007-01-11 | 2007-07-25 | 西北农林科技大学 | 富含α-亚麻酸、杜仲有效成分的杜仲软胶囊的制备方法 |
CN102885310A (zh) * | 2012-10-19 | 2013-01-23 | 中科乐仁(北京)科技发展有限公司 | 一种辅助改善记忆的保健食品组合物及其制备方法 |
CN103238846A (zh) * | 2013-05-31 | 2013-08-14 | 烟台燕园科玛生物技术开发有限公司 | 一种α-亚麻酸软胶囊 |
CN103385315A (zh) * | 2013-08-06 | 2013-11-13 | 南京弘典医药科技有限公司 | 一种具有降血脂作用的植物油组合物及其制备方法与应用 |
CN103598587A (zh) * | 2013-11-20 | 2014-02-26 | 山西振东制药股份有限公司 | 一种具有辅助降血脂作用的保健食品及其制备方法 |
CN104256610A (zh) * | 2014-10-11 | 2015-01-07 | 汤臣倍健股份有限公司 | 一种辅助降血脂的保健组合物及软胶囊 |
Non-Patent Citations (2)
Title |
---|
李春香等: "DHA和EPA的生理功能及开发前景", 《唐山师范学院学报》 * |
陈殊贤等: "微藻油和鱼油中DHA的特性及应用研究进展", 《食品科学》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104799298A (zh) * | 2015-05-20 | 2015-07-29 | 曾晓飞 | 一种以虾青素与欧米伽3结合的营养补充液 |
CN104856055A (zh) * | 2015-05-20 | 2015-08-26 | 曾晓飞 | 一种以虾青素与欧米伽3结合的食品补充剂 |
CN105124586A (zh) * | 2015-09-18 | 2015-12-09 | 青岛琅琊台集团股份有限公司 | 一种含葡萄籽油的dha藻油软胶囊复配及其制备方法 |
CN105768098A (zh) * | 2016-02-25 | 2016-07-20 | 深圳市荣格保健品有限公司 | 一种具有改善记忆力的藻油dha软胶囊及其制备方法 |
CN107997120A (zh) * | 2017-10-24 | 2018-05-08 | 深圳市麦金利实业有限公司 | 一种具有辅助改善记忆功能的软胶囊及其制备方法 |
CN108485793A (zh) * | 2018-03-30 | 2018-09-04 | 广州富诺营养科技有限公司 | 一种高稳定性dha藻油的制备方法 |
CN111685326A (zh) * | 2019-03-15 | 2020-09-22 | 王征 | 优你钙dha藻油制备方法 |
CN112273651A (zh) * | 2020-11-07 | 2021-01-29 | 润科生物工程(福建)有限公司 | 一种富含微藻油dha、dpa和epa的软胶囊及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104522649B (zh) | 2016-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104522649B (zh) | 一种含紫苏籽油的dha藻油软胶囊及其制备方法 | |
CN105613789B (zh) | 一种高脂高膳食纤维复合动植物粉末油脂、其制备方法及应用 | |
TWI352122B (en) | A crude oil, a refined oil, and a general food and | |
Guindani et al. | Valorization of chia (Salvia hispanica) seed cake by means of supercritical fluid extraction | |
CN108112762A (zh) | 一种新型功能性软糖及其制备方法 | |
CN103882071B (zh) | 一种微生物油及其制备方法 | |
CN106720458B (zh) | 一种新型人造奶油及其制备方法和应用 | |
CN104000244B (zh) | 一种南极磷虾油软胶囊及其制备方法 | |
WO2020119165A1 (zh) | Dha油脂组合物在凝胶糖果中的应用以及凝胶糖果及其制备方法 | |
CN103815395A (zh) | 蜂胶与红花籽油软胶囊及其制备方法 | |
CN112273651A (zh) | 一种富含微藻油dha、dpa和epa的软胶囊及其制备方法 | |
CN104673490B (zh) | 米糠油的精炼方法 | |
CN102302155B (zh) | 云南大叶种茶树籽油软胶囊 | |
US20140314911A1 (en) | Deep-Sea Fish Oil Capsule and its Preparation Method | |
CN104127857A (zh) | 一种鱼油软胶囊及其制备方法 | |
CN102106534A (zh) | 一种用于辅助降血脂的组合物及其制备方法 | |
CN103651968B (zh) | 一种大鲵紫苏调和油及其制备方法 | |
CN105768107A (zh) | 用于改善记忆力的组合物及其制备方法和应用 | |
CN113575698B (zh) | 一种鱼油软胶囊及其制备方法和应用 | |
CN108201135A (zh) | 一种鱼油软胶囊及其制备方法 | |
CN101305754A (zh) | 一种调节血脂保健食用油及其制备方法 | |
CN103652924A (zh) | 一种复方葡萄籽油软胶囊及其制备方法 | |
CN101978950A (zh) | α-亚麻酸酯脂肪乳静脉注射液及其制造方法 | |
CN110236197A (zh) | 海参肠卵油组合物、海参肠卵油软胶囊及其制备方法 | |
CN103622016A (zh) | β-环糊精包合亚麻油微胶囊的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231218 Address after: Building A, Building 03-12, Liantang Industrial Zone, Jinping District, Shantou City, Guangdong Province, 515000 Patentee after: Guangdong Zhenpin Health Technology Co.,Ltd. Address before: 363500 Jindu Industrial Concentration Zone, Zhao'an, Zhangzhou City, Fujian Province National Demonstration Base for Science and Technology to Revitalize the Sea Industry Patentee before: RUNKE BIOENGINEERING (FUJIAN) CO.,LTD. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Building A, Building 03-12, Liantang Industrial Zone, Jinping District, Shantou City, Guangdong Province, 515000 Patentee after: Guangdong Peizhi Biotechnology Co.,Ltd. Country or region after: China Address before: Building A, Building 03-12, Liantang Industrial Zone, Jinping District, Shantou City, Guangdong Province, 515000 Patentee before: Guangdong Zhenpin Health Technology Co.,Ltd. Country or region before: China |